We first investigated the methylation level of each CpG site or cluster in the promoters of EPHX1, SRD5A1, and CYP11A1 in 64 peripheral blood DNA samples (32 PCOS patients and 32 healthy controls). The gene discussed is EPHX1; the disease is polycystic ovary syndrome.